Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
Carregando...
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
CADERNOS SAUDE PUBLICA
Autores
OLIVEIRA JUNIOR, Haliton Alves de
Citação
CADERNOS DE SAUDE PUBLICA, v.35, n.9, article ID e00087219, 6p, 2019
Resumo
Palavras-chave
Referências
- Agencia Nacional de Vigilancia Sanitaria, 0032017GPBIOGGMEDANV
- Agencia Nacional de Vigilancia Sanitaria, 1 MED BIOL COMP REG
- Azevedo VF, 2019, JCR-J CLIN RHEUMATOL, V25, P91, DOI 10.1097/RHU.0000000000000881
- Azevedo VF, 2015, AUTOIMMUN REV, V14, P769, DOI 10.1016/j.autrev.2015.04.014
- Banco de Precos em Saude, COMPR PUBL SIASG INF
- BioredBrasil, CONH POS QUEST BIOR
- Canadian Agency for Drugs and Technologies in Health, PAN CAN ONC DRUG REV
- Castaneda-Hernandez G, 2019, PHARMACOEPIDEM DR S, V28, P1035, DOI 10.1002/pds.4785
- Declerck P, 2018, CLIN THER, V40, P798, DOI 10.1016/j.clinthera.2018.03.018
- Departamento de Ciencia e Tecnologia Secretaria de Ciencia Tecnologia e Insumos Estrategicos Ministerio da Saude., 2014, DIR MET DIR AV EC
- Departamento de Ciencia e Tecnologia Secretaria de Ciencia Tecnologia e Insumos Estrategicos Ministerio da Saude, 2018, REV CIENCIAS SUS
- Endrenyi L, 2017, BIOSIMILAR DRUG PROD
- Faccin F, 2016, EXPERT OPIN BIOL TH, V16, P1445, DOI 10.1080/14712598.2017.1238454
- Feagan BG, 2019, ALIMENT PHARM THER, V49, P31, DOI 10.1111/apt.14997
- Fernandes GS, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20177214, 10.1590/1414-431x20177214]
- Food and Drug Administration, BIOS INT PROD
- Garcia R., 2016, J BRAS EC SAUDE, V8, P61
- Garcia R, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0564-1
- Giuliani R, 2019, ESMO OPEN, V4, DOI 10.1136/esmoopen-2018-000460
- Hastier-De Chelle A, 2019, GASTROENTEROLOGY, V156, pS955
- International Network of Agencies for Health Technology Assessment, GLOSS HTA 2018
- Jacobs I, 2017, BIODRUGS, V31, P1, DOI 10.1007/s40259-016-0207-0
- Kay J, 2018, ANN RHEUM DIS, V77, P165, DOI 10.1136/annrheumdis-2017-211937
- McKinnon RA, 2018, BIODRUGS, V32, P27, DOI 10.1007/s40259-017-0256-z
- Merlin T, 2014, INT J TECHNOL ASSESS, V30, P430, DOI 10.1017/S0266462314000543
- Mestre-Ferrandiz J, 2014, BRIEFING, V54
- Ministerio da Saude, 9 FOR LAT AM BIOSS P
- Ministerio da Saude, ENQ PUBL MED BIOL
- Moots R, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0658-4
- O'Callaghan J, 2019, EUR J CLIN PHARMACOL, V75, P1, DOI 10.1007/s00228-018-2542-1
- Oliveira P., 2017, SENADO NOTICIAS 0815
- Reiland JB, 2017, GABI J, V6, P61, DOI 10.5639/gabij.2017.0602.014
- Stewart A, 2010, CURR MED RES OPIN, V26, P2119, DOI 10.1185/03007995.2010.505137
- The Canadian Agency for Drugs and Technologies in Health, 2018, BIOS REG HLTH TECHN
- Torres P, 2017, J BRAS EC SAUDE, V9, P39
- Torres P, 2018, BLOG ARTRITE RE 0117
- World Health Organization, 2009, GUID EV SIM BIOTH PR
- Yoo DH, 2018, EXPERT REV CLIN IMMU, V14, P557, DOI 10.1080/1744666X.2018.1490178